Small Fiber Neuropathy Skin Biopsy: What to Expect and How to Interpret Results

Small fiber neuropathy (SFN) is a condition affecting the small unmyelinated C-fibers and thinly myelinated Aδ-fibers that carry pain, temperature, and autonomic signals. Unlike large fiber neuropathy (which causes weakness and loss of reflexes), SFN produces burning pain, allodynia, autonomic dysfunction, and abnormal temperature sensation — with a normal nerve conduction study. The skin punch biopsy, which measures intraepidermal nerve fiber density (IENFD), is the gold standard diagnostic test for SFN.

Why Standard Nerve Tests Miss SFN

Standard nerve conduction studies (NCS) and electromyography (EMG) measure large myelinated nerve fibers — the ones responsible for motor function, vibration sense, and deep tendon reflexes. Small C-fibers and Aδ-fibers are too small to be detected by standard NCS. This is why patients with SFN often have "normal" nerve conduction studies despite significant neuropathic symptoms — a source of enormous frustration and diagnostic delay.

The skin biopsy directly counts the small nerve fibers in the epidermis, providing an objective measure of small fiber density that NCS cannot detect.

The Skin Punch Biopsy Procedure

The skin punch biopsy for SFN is a minor outpatient procedure performed under local anesthesia. The standard protocol (established by the European Federation of Neurological Societies) involves:

Sites: Two or three 3mm punch biopsies, typically taken from the distal leg (10 cm above the lateral malleolus), the proximal thigh, and sometimes the distal thigh. The distal-to-proximal gradient of nerve fiber loss is diagnostically important — a dying-back pattern (worse distally) suggests a length-dependent neuropathy, while a non-length-dependent pattern suggests a different etiology.

Procedure: Local anesthetic (lidocaine) is injected, a 3mm circular punch is used to remove a small cylinder of skin, and the wound is closed with a single suture or Steri-Strip. The procedure takes 15–20 minutes and leaves a small scar.

Processing: The biopsy is fixed in paraformaldehyde and stained with an antibody against PGP 9.5 (a pan-neuronal marker) to visualize the nerve fibers. Fibers are counted under a confocal microscope and expressed as fibers per millimeter of epidermal length.

Interpreting Your Results

Results are reported as intraepidermal nerve fiber density (IENFD) in fibers/mm, compared to age- and sex-matched normative values. The key parameters are:

Reduced IENFD: Below the 5th percentile for age and sex is the standard diagnostic threshold for SFN. Some labs use the 10th percentile. A reduced IENFD at the distal leg site is the most sensitive finding.

Distal-to-proximal gradient: A significant reduction at the distal site compared to the proximal site (typically >20% difference) suggests length-dependent SFN, which is associated with metabolic, toxic, and hereditary causes.

Morphological changes: In addition to fiber density, pathologists may report abnormal fiber morphology — swollen axons, fragmented fibers, or reduced branching — which can provide additional diagnostic information.

Common Causes Found After SFN Diagnosis

A positive skin biopsy is the beginning, not the end, of the diagnostic workup. Common underlying causes include:

• Diabetes and prediabetes (glucose tolerance test, HbA1c)
• Sjogren's syndrome (anti-SSA/SSB antibodies, lip biopsy)
• MCAS (tryptase, 24-hour urine histamine, prostaglandins)
• Autoimmune (ANA, anti-CASPR2, anti-FGFR3 antibodies)
• Genetic (SCN9A, SCN10A, SCN11A sodium channel variants — tested by genetic panel)
• Celiac disease (anti-tTG, anti-DGP antibodies)
• Thyroid disease (TSH, free T4, anti-TPO)
• Vitamin deficiencies (B12, B6, folate, copper)

Approximately 50% of SFN cases are idiopathic even after thorough workup, though this percentage decreases with more comprehensive testing including genetic panels and autoantibody screens.

SFN and Dysautonomia

SFN frequently co-occurs with dysautonomia because the same small C-fibers that carry pain signals also carry autonomic signals to blood vessels, sweat glands, and visceral organs. Patients with SFN often have:

• Orthostatic intolerance (POTS or orthostatic hypotension)
• Abnormal sweating (anhidrosis or hyperhidrosis)
• Gastroparesis or irritable bowel syndrome
• Bladder dysfunction
• Temperature dysregulation

The QSART (quantitative sudomotor axon reflex test) measures sweat gland function and is often abnormal in SFN patients with autonomic involvement, even when IENFD is borderline.

ChatDys resources: If you have been diagnosed with SFN, upload your biopsy results and lab work to Biomarkers. Upload your genetic data to Genetics to check for SCN9A/SCN10A/SCN11A sodium channel variants. Track your neuropathic pain and autonomic symptoms in the Health Tracker.